{"Content: ":"Regdanvimab, sold under the brand name Regkirona, is a human monoclonal antibody used for the treatment of COVID-19.[4] The antibody is directed against the spike protein of SARS-CoV-2. It is developed by Celltrion.[6][7] The medicine is given by infusion (drip) into a vein.[4][8] The most common side effects include infusion-related reactions, including allergic reactions and anaphylaxis.[4] Regdanvimab was approved for medical use in the European Union in November 2021.[4][5] In the European Union, regdanvimab is indicated for the treatment of adults with COVID-19 who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19.[4] In March 2021, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) started a rolling review of data on regdanvimab.[9][10] In October 2021, the EMA started evaluating an application for marketing authorization for the monoclonal antibody regdanvimab (Regkirona) to treat adults with COVID-19 who do not require supplemental oxygen therapy and who are at increased risk of progressing to severe COVID-19.[11] The applicant is Celltrion Healthcare Hungary Kft.[11] The European Medicines Agency (EMA) concluded that regdanvimab can be used for the treatment of confirmed COVID-19 in adults who do not require supplemental oxygen therapy and who are at high risk of progressing to severe COVID-19.[8] In November 2021, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended granting a marketing authorization in the European Union for regdanvimab (Regkirona) for the treatment of COVID-19.[12][13] The company that applied for authorization of Regkirona is Celltrion Healthcare Hungary Kft.[13] Regdanvimab was approved for medical use in the European Union in November 2021.[4][5] Regdanvimab is the international nonproprietary name (INN).[14]  This antiinfective drug article is a stub. You can help Wikipedia by expanding it. This monoclonal antibody\u2013related article is a stub. You can help Wikipedia by expanding it. This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it.","Title":"Regdanvimab - Wikipedia","KeyID":"11274","URL":"https://en.wikipedia.org/wiki/Regdanvimab"}